Chemed (CHE) PT Raised to $275 at Oppenheimer Following 4Q Beat
Tweet Send to a Friend
Oppenheimer raised its price target on Chemed (NYSE: CHE) to $275.00 (from $270.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
